pembrolizumab,nivolumab,ipilimumab
merck,bms
['melsm', 'hncsm', 'melanoma', 'kcsm,(-skcsm)', 'check,mate,914', 'keynote-412', 'keynote,91', 'renal,(-adrenal)', 'checkmate 914', 'niche-2']
#esmo22 presidential symposium ii starting at 16:30 6.p (paris auditorium): localised #renalcellcarcinoma (ph3 checkmate 914), #hnscc (ph3 keynote-412), #melanoma (swog s1801), #coloncancer (niche-2). #kcsm #hncsm #melsm #medtwitter #onctwitter 
The European Society for Medical Oncology (ESMO) is the leading organisation for cancer education and information, supporting the oncology community’s work.